| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/22/2004 | WO2004032967A1 Association between a ppar ligand and an antioxidant agent and use thereof for treating obesity |
| 04/22/2004 | WO2004032952A1 Use of ghrelin for treating malnutrition in gastrectomized individuals |
| 04/22/2004 | WO2004032949A1 Argyrolobium roseum plant extracts for treating diabetes |
| 04/22/2004 | WO2004032924A1 The use of berberine as insulin sensitizer |
| 04/22/2004 | WO2004032920A1 Stabilized pharmaceutical preparation comprising an amorphous active substance |
| 04/22/2004 | WO2004032836A2 Antidiabetic beta-amino heterocylcic dipeptidyl peptidase inhibitors |
| 04/22/2004 | WO2004032716A2 Compounds for modulation of cholesterol transport |
| 04/22/2004 | WO2004022544A8 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
| 04/22/2004 | WO2004019965A3 Thymus-based tolerogenic approaches for type i diabetes. |
| 04/22/2004 | WO2004010945A3 Cyclooxygenase- 2 selective inhibitors, compositions and methods of use |
| 04/22/2004 | WO2004009784A3 Novel inhibitors of kinases |
| 04/22/2004 | WO2004005243A3 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives |
| 04/22/2004 | WO2004003201A3 Antisense modulation of lrh1 expression |
| 04/22/2004 | WO2004002986A3 Novel benzimidazole derivatives |
| 04/22/2004 | WO2003101958A3 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors |
| 04/22/2004 | WO2003078403A3 Derives d’aminoindazoles comme inhibiteurs de proteine-kinase |
| 04/22/2004 | WO2003068937A3 Embryonic-like stem cells derived from post-partum mammalian placenta and uses and methods of treatment using said cells |
| 04/22/2004 | WO2003057722A3 Cyclic tetrapeptide compound and use thereof |
| 04/22/2004 | WO2003027248A8 Antibody inhibitors of gdf-8 and uses thereof |
| 04/22/2004 | WO2003020763A9 Soluble t cell receptor |
| 04/22/2004 | WO2002100148A3 Treatment or prophylaxis of insulin-producing cell graft rejection |
| 04/22/2004 | WO2002098857A8 New indole derivatives with 5-ht6 receptor affinity |
| 04/22/2004 | WO2002074752A8 Metalloproteinase inhibitors |
| 04/22/2004 | US20040077896 Compounds for the treatment of metabolic disorders |
| 04/22/2004 | US20040077877 Jun n-terminal kinase inhibitors |
| 04/22/2004 | US20040077871 Processes and intermediates useful in preparing beta-3-adrenergic receptor agonists |
| 04/22/2004 | US20040077851 Receptor selective cannabimimetic aminoalkylindoles |
| 04/22/2004 | US20040077828 Proteins containing the motif that are capable of binding to secreted Frizzled-related protein (Sfrp) family members |
| 04/22/2004 | US20040077730 Carbocyclic halo amines such as N,N-dimethyl-1-(1-(4-chloro-phenyl)cyclobutyl)-3-methylbutyl amine hydrochloride, used for reducing insulin resistance in humans having diabetes |
| 04/22/2004 | US20040077719 Food supplements, feed additives, dietetic, cosmetics |
| 04/22/2004 | US20040077708 Atorvastatin calcium; bioavailability |
| 04/22/2004 | US20040077707 Pyrrole based inhibitors of glycogen synthase kinase 3 |
| 04/22/2004 | US20040077706 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome |
| 04/22/2004 | US20040077693 Integrin receptor inhibitors |
| 04/22/2004 | US20040077689 Abc expression promoters |
| 04/22/2004 | US20040077684 Piperidinyl compounds that selectively bind integrins |
| 04/22/2004 | US20040077681 Pyrazolo[3,4-c]pyridines as gsk-3 inhibitors |
| 04/22/2004 | US20040077671 Sorbitol dehydrogenase inhibitors |
| 04/22/2004 | US20040077670 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/22/2004 | US20040077667 Quinazolinone derivatives |
| 04/22/2004 | US20040077654 Anticholesterol agents; cardiovascular disorders |
| 04/22/2004 | US20040077645 Xanthine derivatives,production and use thereof as medicament |
| 04/22/2004 | US20040077642 Pyrimidine compounds |
| 04/22/2004 | US20040077630 Allosteric adenosine receptor modulators |
| 04/22/2004 | US20040077620 Hypoglycemic agent |
| 04/22/2004 | US20040077614 High, sustained blood concentration levels even during pregnacy without hepatic side effects; 3,17-dipropionate or dihexanoate; multiple sclerosis |
| 04/22/2004 | US20040077613 Stimulation of preadipocyte differentiation; insulin resis-tance syndrome, dyslipidemia, type 2 diabetes; LXR alpha receptor agonists |
| 04/22/2004 | US20040077536 Human and rat pgc-3, ppar-gamma coactivations and splice variants thereof |
| 04/22/2004 | US20040077535 Novel physiologically active peptide and use thereof |
| 04/22/2004 | US20040077531 Regulating luteotropic hormone secretion; amino acid sequence 35 |
| 04/22/2004 | US20040077528 Entrapping active agent in fumaryl diketopiperazine derivative and solvent washing out impurities; purified insulin for pulmonary administration |
| 04/22/2004 | US20040077525 Novel treatment |
| 04/22/2004 | US20040077079 Methods, kits and production plant for use in the production of cell colony forming units from a mammalian tissue explant and to the use of cells from such cell colony forming units in treatment of mammals suffering from tissue disorders |
| 04/22/2004 | US20040077051 LSR receptor, its activity, its cloning, and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications |
| 04/22/2004 | US20040076667 Sustained release pharmaceutical composition containing metformin hydrochloride |
| 04/22/2004 | US20040076645 Ghrelin-carrier conjugates |
| 04/22/2004 | US20040076628 Use of IL-18 inhibitors for the treatment and/or prevention of atherosclerosis |
| 04/22/2004 | US20040076608 Cytokine uses; compositions; methods |
| 04/22/2004 | DE10247910A1 Oral appetite-suppressant comprises capsule of compressed Konjak meal which is insoluble in gastro-intestinal fluid, but swells in it |
| 04/22/2004 | DE10247680A1 New benzotriazole-1-carboxylic acid amide or ester compounds, are hormone-sensitive lipase inhibitors useful for treating non-insulin dependent diabetes or diabetic syndrome |
| 04/22/2004 | CA2501967A1 Association between a heterocyclic compound stimulating lipid and carbohydrate metabolisms and an antioxidant agent for treating obesity |
| 04/22/2004 | CA2501964A1 Association between a ppar ligand and an antioxidant agent and use thereof for treating obesity |
| 04/22/2004 | CA2501935A1 Argyrolobium roseum plant extracts for treating diabetes |
| 04/22/2004 | CA2501875A1 Cap-binding protein |
| 04/22/2004 | CA2501685A1 Compounds for modulation of cholesterol transport |
| 04/22/2004 | CA2501456A1 Novel heterocyclic analogs of diphenylethylene compounds |
| 04/22/2004 | CA2500763A1 Carboxyalkoxy-substituted acyl-carboxyphenyl-urea derivatives, production method and use thereof as medicine |
| 04/22/2004 | CA2499586A1 Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors |
| 04/21/2004 | EP1411055A1 Thiazolidinedione derivative and its use as antidiabetic |
| 04/21/2004 | EP1411054A1 Thiazolidinedione derivative and its use as antidiabetic |
| 04/21/2004 | EP1411049A1 Estrogen Agonists/Antagonists |
| 04/21/2004 | EP1410800A1 Use of 1- 4-(5-cyanoindol-3-yl)butyl -4-(2-carbamoylbenzofuran-5-yl)piperazine and its physiologically acceptable salts |
| 04/21/2004 | EP1410797A1 Solid oral dosage forms comprising valsartan |
| 04/21/2004 | EP1410796A2 New therapeutic uses for potassium channel openers |
| 04/21/2004 | EP1410721A1 Process for manufacturing a palatinose-containing enteral food |
| 04/21/2004 | EP1410018A1 Method for detecting modultators of notch signalling |
| 04/21/2004 | EP1409680A2 Novel human proton-gated channels |
| 04/21/2004 | EP1409679A2 Nov-x proteins and nucleic acids encoding same |
| 04/21/2004 | EP1409677A2 Receptors and membrane-associated proteins |
| 04/21/2004 | EP1409670A2 Synthetic double stranded oligonucleotides for targeted inhibition of gene expression |
| 04/21/2004 | EP1409655A2 Immunoglobulin superfamily proteins |
| 04/21/2004 | EP1409645A1 Probiotic lactobacillus salivarius strains |
| 04/21/2004 | EP1409644A1 Probiotic bifidobacterium strains |
| 04/21/2004 | EP1409540A2 Melanocortin receptor ligands |
| 04/21/2004 | EP1409535A2 Human secreted proteins |
| 04/21/2004 | EP1409531A2 Heterocarpine, a human ghrh-binding protein |
| 04/21/2004 | EP1409523A2 Pancam nucleic acids and polypeptides |
| 04/21/2004 | EP1409521A2 Cyclic peptides as potent and selective melanocortin-4 receptor agonists |
| 04/21/2004 | EP1409496A1 Phosphoglycan messengers and their medical uses |
| 04/21/2004 | EP1409494A1 Stabilized derivatives of ascorbic acid -3- phosphate |
| 04/21/2004 | EP1409489A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 04/21/2004 | EP1409487A1 Pteridinones as kinase inhibitors |
| 04/21/2004 | EP1409485A1 Novel immunomodulating compounds |
| 04/21/2004 | EP1409481A1 Quinoline derivatives and their use as tyrosine kinase inhibitors |
| 04/21/2004 | EP1409477A1 Piperidine derivatives as nmda receptor antagonists |
| 04/21/2004 | EP1409468A2 Guanidinobenzamides as mc4-r agonists |
| 04/21/2004 | EP1409448A1 Process for the preparation of (r)- or (s)-aminocarnitine inner salt, the salts and derivatives thereof |
| 04/21/2004 | EP1409102A1 Method and installation for setting in adsorbed state on a porous support active compounds contained in a product |
| 04/21/2004 | EP1409077A2 Thermotherapy via targeted delivery of nanoscale magnetic particles |
| 04/21/2004 | EP1409015A1 Methods for treating or preventing skin disorders using cd2-binding agents |